VOYA Investment Management
CTXR icon

VOYA Investment Management’s Citius Pharmaceuticals CTXR Stock Holding History

VOYA Investment Management’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,916
Closed -$43K – 2841
2024
Q1 		$43K Sell
1,916
-159
-8% -$2.9K ﹤0.01% 2744
2023
Q4 		$39.2K Hold
2,075
– – ﹤0.01% 2871
2023
Q3 		$35.5K Hold
2,075
– – ﹤0.01% 2879
2023
Q2 		$62.3K Buy
+2,075
New +$68.3K ﹤0.01% 2879
2022
Q2 		– Sell
-1,751
Closed -$78K – 2800
2022
Q1 		$78K Hold
1,751
– – ﹤0.01% 2547
2021
Q4 		$67K Sell
1,751
-61
-3% -$2.77K ﹤0.01% 2721
2021
Q3 		$92K Hold
1,812
– – ﹤0.01% 2753
2021
Q2 		$158K Buy
+1,812
New +$109K ﹤0.01% 2670

Other funds holding CTXR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VOYA Investment Management's CTXR Position: Q2 2024 in Review

VOYA Investment Management sold out of Citius Pharmaceuticals (CTXR) in Q2 2024, closing a stake of 1,916 shares — an estimated $43K sold.

VOYA Investment Management first reported a position in CTXR in Q2 2021 and held it in 8 quarters. The position peaked at $158K in Q2 2021. 72 funds tracked by Wall St. Rank hold CTXR as of Q2 2024.

  • VOYA Investment Management reported no remaining Citius Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • VOYA Investment Management sold 1,916 Citius Pharmaceuticals shares in Q2 2024, an estimated $43K.
  • VOYA Investment Management first reported a position in Citius Pharmaceuticals in Q2 2021 and held it in 8 quarters.
  • VOYA Investment Management's Citius Pharmaceuticals position peaked at $158K in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2024.

Based on VOYA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.